![Bruno Bruins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bruno Bruins
Directeur/Bestuurslid bij Institute for Translational Vaccinology
Profiel
Bruno Bruins is currently a Member-Supervisory Board at the Institute for Translational Vaccinology and at Intravacc BV.
He previously served as the Minister for Medical Care in the Government of the Netherlands.
Actieve functies van Bruno Bruins
Bedrijven | Functie | Begin |
---|---|---|
Institute for Translational Vaccinology
![]() Institute for Translational Vaccinology BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Directeur/Bestuurslid | 01-01-2021 |
Intravacc BV | Directeur/Bestuurslid | 01-01-2021 |
Eerdere bekende functies van Bruno Bruins
Bedrijven | Functie | Einde |
---|---|---|
Government of the Netherlands | Minister van de Regering | 19-03-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Government of the Netherlands | Government |
Institute for Translational Vaccinology
![]() Institute for Translational Vaccinology BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Health Technology |
Intravacc BV | Health Technology |